Ceribell, Inc.

Ceribell, Inc. operates as a medical device manufacturer focused on electroencephalogram (EEG) technology for acute care settings. The company's primary product is the Ceribell System, a point-of-care EEG platform designed to detect seizures and other neurological abnormalities in hospitalized patients. The system comprises disposable, flexible headbands and headcaps that capture electrical brain activity, along with a pocket-sized, rechargeable battery-operated recorder that transmits EEG signals wirelessly. The company also offers Clarity, an artificial intelligence-powered seizure detection algorithm, and operates an EEG portal that provides real-time remote access to patient EEG data.

The company serves the acute care hospital market, where rapid neurological assessment is critical for patient outcomes. Ceribell's products address the need for portable, operator-independent EEG monitoring in emergency departments, intensive care units, and other acute care environments where traditional EEG systems may be impractical. The company operates primarily in the United States and is headquartered in Sunnyvale, California, with approximately 327 full-time employees.